3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note

• 10-year Treasury yield near 5.3% makes high dividend stocks under $30 more attractive than risk-on growth names • Pfizer, Energy Transfer, and Plains All American offer yields of 6-7% with sub-$30 share prices • Each combines income with growth drivers: Pfizer's pipeline, Energy Transfer's midstream scale, PAA's Permian volumes The 10-year Treasury yield has climbed to around 5.3%, up from 4.78% a month earlier and over a point higher than a year ago, well above its long-term 4.25% average. Rising long-term rates make high-valuation growth stocks less appealing, especially for investors nearing retirement. An alternative is defensive dividend stocks trading under $30 with yields above the 10-year Treasury. Pfizer (PFE) trades below $30, up about 14% in 2026, and yields roughly 6.19% after 16 straight years of dividend increases. While Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) lead in GLP-1, autoimmune, and oncology drugs, Pfizer has about 95 pipeline candidates, though some will fail, as its Seagen-derived lung cancer therapy did in a recent Phase 3 trial. Energy Transfer (ET) is a midstream pipeline operator benefiting from the shift in oil demand toward transport and refining rather than exploration. ET is up over 20% in 2026, yields nearly 7%, and has a consensus price target of $24.36 implying further upside. Plains All American Pipeline (PAA) is a pure-play crude logistics company moving Permian Basin oil to Gulf Coast refiners and export terminals, earning fees based on volume rather than oil price. Q2 2026 adjusted EBITDA was $738 million, with crude oil segment EBITDA up over $100 million from Q1. PAA is up about 32% in 2026, yields about 7%, and has raised its dividend for five consecutive years, though analysts rate it a cautious Hold with a $25.43 price target.